Thrombosis and Affect lability

Summary:

Affect lability is found among people with Thrombosis, especially for people who are female, 60+ old.

The study analyzes which people have Affect lability with Thrombosis. It is created by eHealthMe based on reports of 11 people who have Thrombosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Thrombosis?

Thrombosis (formation of a blood clot inside a blood vessel) is found to be associated with 1,809 drugs and 2,051 conditions by eHealthMe. Check the latest studies of Thrombosis.

What is Affect lability?

Affect lability (emotional incontinence) is found to be associated with 669 drugs and 828 conditions by eHealthMe. Check the latest studies of Affect lability.



On Jul, 18, 2026

11 people who have Thrombosis and Affect Lability are studied.

Would you have Affect lability when you have Thrombosis?

Gender of people who have Thrombosis and experienced Affect Lability *:

  • female: 70 %
  • male: 30 %

Age of people who have Thrombosis and experienced Affect Lability *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 14.29 %
  • 20-29: 14.29 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 71.43 %

Common co-existing conditions for these people *:

  1. Depression: 3 people, 27.27%
  2. High Blood Pressure: 2 people, 18.18%
  3. Breast Cancer: 2 people, 18.18%
  4. Breast Cancer Female: 2 people, 18.18%
  5. Insomnia (sleeplessness): 2 people, 18.18%
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 18.18%
  7. Weight Loss: 1 person, 9.09%
  8. Blood Pressure Abnormal: 1 person, 9.09%
  9. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 9.09%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 9.09%

Common drugs taken by these people *:

  1. Keflex: 2 people, 18.18%
  2. Albuterol: 2 people, 18.18%
  3. Amlodipine: 2 people, 18.18%
  4. Aromasin: 2 people, 18.18%
  5. Lovenox: 2 people, 18.18%
  6. Eliquis: 1 person, 9.09%
  7. Ipratropium Bromide: 1 person, 9.09%
  8. Heparin: 1 person, 9.09%
  9. Haldol: 1 person, 9.09%
  10. Glucosamine Sulfate: 1 person, 9.09%

Common symptoms for these people *:

  1. Fatigue (feeling of tiredness): 4 people, 36.36%
  2. Vision Blurred: 4 people, 36.36%
  3. Insomnia (sleeplessness): 3 people, 27.27%
  4. Weakness: 3 people, 27.27%
  5. Thinking Abnormal: 3 people, 27.27%
  6. Memory Loss: 3 people, 27.27%
  7. Cerebral Haemorrhage (bleeding within the brain): 2 people, 18.18%
  8. Brain Damage: 2 people, 18.18%
  9. Drowsiness: 2 people, 18.18%
  10. Dizziness: 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Affect lability?

- Check whether Affect lability is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Affect lability:

All the conditions that are associated with Affect lability:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Affect lability and Thrombosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: